Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-23-020162
Filing Date
2023-05-30
Accepted
2023-05-30 16:56:28
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A absi-20221231.htm   iXBRL 10-K/A 77331
2 EX-31.3 exhibit313-2022q410xkxamen.htm EX-31.3 10124
3 EX-31.4 exhibit314-2022q410xkxamen.htm EX-31.4 10127
  Complete submission text file 0001628280-23-020162.txt   333595

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT absi-20221231.xsd EX-101.SCH 2513
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT absi-20221231_lab.xml EX-101.LAB 40499
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT absi-20221231_pre.xml EX-101.PRE 21484
9 EXTRACTED XBRL INSTANCE DOCUMENT absi-20221231_htm.xml XML 20522
Mailing Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683
Business Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 (360) 949-1041
Absci Corp (Filer) CIK: 0001672688 (see all company filings)

EIN.: 853383487 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40646 | Film No.: 23977383
SIC: 8731 Services-Commercial Physical & Biological Research